BiotechTube
Home/PolyActiva/Vanessa Waddell
VW

Vanessa Waddell

Chief Strategy Officer

PolyActiva

Therapeutic Areas

Ophthalmology

PolyActiva Pipeline

DrugIndicationPhase
PREZIA Glaucoma ImplantGlaucomaPreclinical
RareSight Pediatric Retinal Pro‑drugRare Pediatric Retinal DiseasesPreclinical

Leadership Team at PolyActiva

JS
Jerry St. Peter
Chief Executive Officer
WB
Wes Brazell
Chief Financial Officer
MB
Michael Brubaker, Ph.D.
Chief Scientific Officer
View full PolyActiva profile